One million doses of the Moderna COVID-19 vaccine is expected to arrive in Australia next month with another three million in October. That's some added good news on the fight against the virus, as vaccine supply has been a bit of a problem for NSW.
Most Popular
XRP's 54% drop may be a buy-the-dip chance, but regulatory clarity is key. Volatility remains high.
Nvidia invests $2B in Nebius, fueling AI data center growth. Expect 531% revenue jump, but watch for potential risks.
JPM's $30B+ debt deals test investor risk appetite amid AI valuation dips & war fears.
GSAT's up 171% on revenue growth, but its high P/S ratio suggests waiting for a dip.
ETH Foundation sells 5K ETH to BitMine for $10.2M. BitMine holds $9B ETH, facing $7.5B paper loss.
BYND shares down 99% from IPO, revenue drops 13.3%, losses balloon. Still room for more downside.
Hormuz Strait tensions surge! Oil prices top $100/bbl as Iran war escalates. Risk rises.
Must Read